ALLMedicine™ Pacemakers Center

Sep 15th, 2021 - Magnetic resonance imaging guided radiation therapy (MRgRT) is reported for treating patients with an insertable cardiac monitor (ICM) and implantable cardiac pacemakers (ICP). All treatments were delivered using a 1.5 T MR-Linac. Among the four p...

Aug 31st, 2021 - Leadless pacemakers (LPs) have proven safe and effective, but device revisions remain necessary. Either replacing the LP or implanting a new adjacent LP is feasible. Replacement seems more appealing, but encapsulation and tissue adhesions may hamp...

Aug 2nd, 2021 - Leadless pacemakers (LPs) have revolutionized the field of pacing by miniaturizing pacemakers and rendering them completelty intracardiac, hence reducing complications related to pacemaker pockets and transvenous leads. However, first generation L...

Jul 31st, 2021 - To assess the currently available evidence regarding associations between spinal cord stimulator (SCS) lead type, clinical indications for device placement, and interference between SCSs and cardiac pacemakers (CPMs)/implantable cardioverter-defib...

Jul 23rd, 2021 - Antiarrhythmic drugs are often used in the management of patients with atrial fibrillation (AF). Sotalol is conventionally initiated in the inpatient setting for monitoring efficacy and adverse effects, including QTc interval prolongation and tors...

Jun 9th, 2021 - Further evidence that powerful magnets in some Apple iPhones can interfere with cardiac implantable electronic devices (CIEDs) comes from a small study that also suggests some devices are more susceptible than others. The iPhone 12 Pro Max with Ma...

Jun 27th, 2018 - Patients who got the Nanostim leadless pacemaker instead of a transvenous one had fewer complications through up to 18 months of follow-up, researchers said. Those receiving the leadless cardiac pacemaker (LCP) generally had fewer complications th...

Nov 14th, 2016 - The Centers for Medicare & Medicaid Services aims to cover leadless pacemakers, but only in the context of use in FDA-approved studies, according to a draft of the agency's national coverage determination for the devices. The document details the ...

Jun 29th, 2015 - MILAN, ITALY — Women are being short-changed when it comes to receiving cardiac implantable electronic devices (CIEDs), which is especially concerning because they actually have higher survival rates than men after implantation of certain device t...

Apr 11th, 2014 - The approval of cardiac resynchronization pacemakers and defibrillators manufactured by Medtronic has been expanded to include patients with atrioventricular block and less severe heart failure, the Food and Drug Administration announced on April.